Decrease (-) Restore Default Increase (+)
Bookmark and Share
clear spacerNorton Healthcare Quality Report

Physician Office Care


Most medical care occurs in a physician's office. The indicators in this section apply to care delivered outside the hospital by the physicians of Norton Healthcare Physician Practices. The data we display here are based upon a representative sample of the more than 400,000 visits to these physicians annually. We currently report values only for NCQA indicators.

Diabetes - percent of patients
Number of diabetic patients per 100 who received one or more HbA1c tests during a 12 month period. The HbA1c test indicates the average blood glucose control for the past 2 to 3 months. Monitoring the HbA1c will help the physician determine how the patient is responding to their current treatment and if changes are needed. Includes all patients with Type I and II Diabetes, ages 18-75.(AQA / AQA13) receiving 1 or more HbA1c test(s) high 96.7    
Number of diabetic patients per 100 with a recent HbA1c test indicating their diabetes is not under control. The HbA1c test indicates your average blood glucose control for the past 2 to 3 months. The American Diabetes Association recommends a HbA1c level equal or below 7%. Includes all patients with Type I and II Diabetes, ages 18-75.(AQA / AQA14) with most recent HbA1c level > 9.0% low 22.8    
Number of diabetic patients per 100 who received at least one lipid profile during a 12 month measurement period. People with diabetes may have problems with the levels of cholesterol and other blood fats, also called lipids. Monitoring lipid levels will help the physician determine if treatment is needed. Includes all patients with Type I and II Diabetes, ages 18-75.(AQA / AQA16) receiving at least one LDL-C test high 91.8    
Number of diabetic patients per 100 whose most recent low-density lipoprotein cholesterol (LDL-C) test is < 130 mg/dl. LDL is often called the ‘ bad cholesterol ’ and the recommended level is < 100 mg/dl. High levels can lead to hardening of the arteries and cardiovascular disease. Includes all patients with Type I and II Diabetes, ages 18-75.(AQA / AQA17a) with most recent LDL-C level < 130 mg/dL high 79.8    
Number of diabetic patients per 100 whose most recent low-density lipoprotein cholesterol (LDL-C) test is < 100 mg/dl. LDL is often called the 'bad cholesterol' and the recommended level is < 100 mg/dl. High levels can lead to hardening of the arteries and cardiovascular disease. Includes all patients with Type I and II Diabetes, ages 18-75.(AQA / AQA17b) with most recent LDL-C level < 100 mg/dL high 60.4    
Number of diabetic patients per 100 who received and eye exam by an eye care professional within the last two years. A dilated retinal eye exam or a funduscopic photo (with interpretation by an ophthalmologist or optometrist) during the measurement year or one test within the past two years if criteria for low risk are met is recommended. Diabetics are at risk for developing eye disease and this type of exam is recommended yearly to detect signs of damage to the retina.  Includes all patients with Type I and II Diabetes, ages 18-75. Criteria for low risk are 1) not taking insulin; 2) HbA1c < 8%; 3) no evidence of retinopathy in the prior year.(AQA / AQA18) who received an eye exam/evaluation high 50.5    
Number of diabetic patients per 100 whose most recent blood pressure reading was less than 140/90 mm Hg. Monitoring and controlling your blood pressure will help reduce the high risk for heart attacks and strokes in diabetes. A blood pressure below 130/80 mm Hg is recommended by the American Diabetes Association. Includes all patients with Type I and II Diabetes, ages 18-75.(AQA / AQA15) w/ most recent BP < 140/90 mm/Hg high 80.3    
Prevention, Immunization and Screening - percent of patients
Number of women per 100 who had a mammogram in the last two years. Women who have their breast cancer detected early have more treatment options and improve their chance for survival. Includes women aged 52-69 years within a two year measurement period. Excludes patients who had a bilateral mastectomy.(AQA / AQA1) who had one or more mammograms (women only) high 70.1    
Number of patients per 100 who received appropriate screening for colorectal cancer. The screenings include any of the following: fecal occult blood test, sigmoidoscopy, double contrast barium enema, colonoscopy. Screening for colorectal cancer can reduce the mortality rate significantly. Includes all patients age 51-80 years within a 1-10 year measurement period, based on the type of screening. Excludes patients with the diagnosis of colorectal cancer or patients who had a total colectomy.(AQA / AQA2) screened for colorectal cancer high 68.3    
Number of women per 100 who received a PAP test within the last three years. Cervical cancer screening decreases disease incidence and mortality. Includes all women age 21-64 years in a three year measurement period. Excludes patients who have had a complete/total hysterectomy.(AQA / AQA3) who received one or more PAP tests (women only) high 60.3    
Number of patients per 100 who received an influenza vaccination from September through February of the year prior to the measurement period. Includes all patients > 50 years of age at the beginning of the one-year measurement period. Excludes patients with egg allergy, patients with adverse reaction to influenza vaccination, patients with other medical reason(s) documented by the practitioner for not receiving an influenza vaccination, or other patient reason(s).(AQA / AQA6) age 50 and older given influenza vaccination high 53.6    
Number of patients per 100 who have ever received a pneumonia vaccination. Includes all patients > 65 years of age. Excludes patients with previous anaphylactic reaction to the vaccine, patients with other medical reason(s) documented by the practitioner for not receiving a pneumonia vaccination, or other patient reason(s).(AQA / AQA7) age 65 and older given pneumococcal vaccination high 51.1    
Number of patients per 100 who were asked about their smoking. This helps the doctor identify who is a smoker and offer advice on how to quit smoking. Smoking increases the risk of heart attack, stroke, lung disease and many other health problems. Includes all patients > 18 years of age at the beginning of the two-year measurement period.(AQA / AQA4) queried for tobacco use during 2-yr period high 98.4    
Number of patients per 100 identified as smokers who were advised to quit. No matter what your age or how long you have smoked, quitting will help you live longer. Ex-smokers have an improved quality of life with fewer illnesses. Includes all patients > 18 years of age identified as tobacco users at the beginning of the two-year measurement period.(AQA / AQA5) who smoke and received cessation intervention high #    
Coronary Artery Disease (CAD) - percent of patients
Number of patients per 100 with coronary artery disease (CAD) who were prescribed lipid-lowering therapy. The ACC (American College of Cardiology) and the AHA (American Heart Association) recommends patients with elevated cholesterol levels use lipid lowering drugs to help reduce the risk of heart attack and stroke. Includes all patients with CAD > 18 years of age. Excludes patients with documentation that lipid-lowering therapy was not indicated, or other reason(s) documented by the practitioner for not prescribing lipid-lowering therapy, or patient reason(s).(AQA / AQA8) prescribed a lipid-lowering medication high 74.5    
Heart Failure - percent of patients
Number of heart failure patients per 100 with results of LVF (left ventricular function) assessment recorded. LVF is a test performed to determine if the left ventricle of the heart is working correctly. Assessment of heart function will help the physician determine the degree of heart failure and what therapy is most appropriate for the patient. Includes all patients with heart failure > 18 years of age.(AQA / AQA12) given LVF assessment high 99.8    
Number of heart failure patients per 100 who were prescribed angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) therapy. ACEI and/or ARB drugs improve survival rates and are recommended therapy for patients with heart failure. Includes all heart failure patients > 18 years of age with LVEF < 40 % or with moderately or severely depressed left ventricular systolic function. Excludes patients with allergy/contraindications to ACE inhibitor or ARB, patients with other medical reason(s) documented by the practitioner for not prescribing ACE inhibitor or ARB therapy, or other patient reason(s).(AQA / AQA11) w/ LVSD prescribed ACEI/ARB (med) high 94.5    
Asthma - percent of patients
Number of asthma patients per 100 who were prescribed either the preferred long-term control medication (inhaled corticosteroid) or an acceptable alternative treatment. The appropriate drug therapy will help patients maintain long term control of their asthma. Includes all patients aged 5-40 years with mild, moderate, or severe persistent asthma. Excludes patients with documented reason(s) for not prescribing either the preferred long-term control medication or an acceptable alternative treatment.(AQA / AQA20) prescribed proper drug therapy (any severity) high 99.0    
Respiratory Infections and Pharyngitis - percent of pediatric patients
Number of pediatric patients per 100 who were given a diagnosis of upper respiratory infection (URI) and were not given a prescription for antibiotic medication within 3 days of the episode date. This measure evaluates appropriate use of antibiotics in children with colds. Includes children age 3 months as of July 1 of the year prior to the measurement year to 18 years as of June 30 of the measurement year who had an outpatient visit with only a diagnosis of nonspecific upper respiratory infection during the intake period. Excludes episodes where antibiotics were prescribed in the 30 days prior to the episode.(AQA / AQA24) w/ URI not given antibiotic w/i 3 days of episode high 76.6    
Number of pediatric patients per 100 who were diagnosed with pharyngitis, prescribed an antibiotic and received a group A streptococcus test in a 7-day period. Early strep A testing may improve treatment of patients with pharyngitis by allowing prompt and appropriate therapy. Includes Patients with a diagnosis of Pharyngitis, ages 2.5 - 18.5 yrs., who receive a prescription for an ABX. Excludes cases where ABX were prescribed in the 30 days prior to the episode or ABX active at the time of the episode.(NQF) w/ sore throat given proper lab test before antibiotic prescription high 98.6    

Medical Care

Cancer
Pregnancy & Prenatal Classes
Weight Loss
Orthopedics
Heart Disease
Neurology
Women's Health
More Medical Care

Locations

Hospitals
Immediate Care
Health Centers
Emergency Room
Doctors Offices
Specialists
Affiliate Hospitals

Patients and Visitors

MyChart
Pay Your Bill
Request an Appointment
Get Healthy
Support Groups
Fitness Groups
Mobile Applications
Clinical Trials
Online Nursery
Classes and Events
Send an eCard
Patient Stories
Places to Stay
Say Thanks

About Us

Quality Report 
Careers
Ways to Help
Community Outreach
Contact Us
(502) 629-1234

Connect with us

© 2014 Norton Healthcare
Serving Kentucky and Southern Indiana